SIMAL-pilot

None

Plant alkaloid. FDA approved use on small-cell lung cancer, testicular cancer.

This drug should be coded

None

None

None

None

A prophylactic detoxifying agent used to inhibit hemorrhagic cystitis caused by ifosfamide. FDA approved for bladder protection when using cyclophosphamide (prevents bladder toxicity).

This drug should NOT be coded

None

None

None

The pharmacologically active form of folic acid. FDA approved uses as 1st line colorectal carcinoma in combination with 5-FU and to diminish methotrexate toxicity.

This drug should NOT be coded

None

Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)

This drug should be coded

None

Code Prednisone when it is part of a drug regimen.

Do not code Prednisone when it is given to treat symptoms or as a single agent. In most cases when Prednisone is given by itself and not as part of a drug regimen, it does not affect the cancer and would not be coded as treatment.

Please see remarks for additional information

None

None

The official preparation, usually a topical agent and its salts are used in the treatment of inflammations, allergies, pruritus, collagen diseases such as rheumatoid arthritis and systemic lupus erythematosus, some neoplasms, acute or chronic adrenocortical insufficiency, severe status asthmaticus, and shock.

DO NOT CODE unless the physician clearly states it is being prescribed to treat/destroy the cancer cells.

Please see remarks for additional information